Apotex Health Corp. (APTX) Stock Statistics & Valuation Metrics

Apotex Health Corp. has a market cap or net worth of C$7.77B. The enterprise value is C$10.14K.

Apotex Health Corp. has 228,499,020 shares outstanding. The number of shares has decreased by -2.65% in one year.

Apotex Health Corp.’s return on equity (ROE) is -0.67 and return on invested capital (ROIC) is 17.62%.

The current PE Ratio of Apotex Health Corp. is 21.1. Apotex Health Corp.’s PEG ratio is 0.12.

In the last 12 months, Apotex Health Corp. had revenue of 3.49B and earned 373.78M in profits. Earnings per share was 1.61.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Apotex Health Corp. pays an annual dividend of C$0.06, resulting in a dividend yield of 0.18%

Apotex Health Corp. upcoming earnings date is Aug 12, 2026, Before Open (Confirmed).

Apotex Health Corp. as a current ratio of 1.50, with Debt / Equity ratio of ―

In the past 12 months, Apotex Health Corp. has paid 146.09M in taxes.

Apotex Health Corp. EV to EBITDA ratio is 10.66, with an EV/FCF ratio of 21.18.

Apotex Health Corp. has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of 22.52%, and net profit margin of 10.71%.

The average price target for Apotex Health Corp. is C$40.75, which is 11.43% higher than the current price. The consensus rating is Strong Buy